Crossmark

Identification of potential immunomodulators from Pulsatilla decoction that act on therapeutic targets for ulcerative colitis based on pharmacological activity, absorbed ingredients, and in-silico molecular docking

Crossref DOI link: https://doi.org/10.1186/s13020-022-00684-7

Published Online: 2022-11-24

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Deng, Li-rong

Han, Qian

Zou, Min

Chen, Fang-jun

Huang, Chang-yin

Zhong, Yi-ming

Wu, Qian-yan

Tomlinson, Brian

Li, Yan-hong http://orcid.org/0000-0002-1410-2484
Funding

Funding for this research was provided by:

the National Natural Science Foundation of China (82174048)
License Information

Text and Data Mining valid from 2022-11-24

Version of Record valid from 2022-11-24
More Information

Article History

Received: 19 July 2022

Accepted: 3 November 2022

First Online: 24 November 2022

Declarations

:

: All animal care and experimental procedures were approved by the Animal Care and Use Committee at South China University of Technology (SCUT) (approval number: 2017004).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below